格隆汇3月1日丨中国中车(601766.SH)发布公告，董事会会议审议通过了《关于聘任中国中车股份有限 公司财务总监(总会计师)的议案》，同意聘任曲孝利为公司财务总监(总会计师)，任期为自公司董事会 审议通过之日起至第四届董事会任期结束之日止。 ...

Core Viewpoint - The company reported that in February, it sold 12,744 new energy vehicles, contributing to a total of 30,773 units sold in the first two months of the year [1] Group 1 - In February, the sales of new energy vehicles reached 12,744 units [1] - Cumulative sales for January and February amounted to 30,773 units [1]

Event Overview - In FY2026H1, the company's revenue, net profit, and operating cash flow were 3.376 billion, 676 million, and 996 million yuan, respectively, representing year-on-year growth of 7.0%, 11.9%, and 21.1% [1] - Government subsidies amounted to 50.21 million yuan, and the net profit excluding these subsidies was 626 million yuan, showing a year-on-year increase of 15.5% [1] - The company declared an interim dividend of 0.52 HKD per share, with a dividend yield of 5.18% [1] Brand Performance - Revenue growth by brand in FY2026H1 was as follows: JNBY 1.860 billion, Su Xie 389 million, jnby by JNBY 495 million, LESS 394 million, and emerging brands 237 million, with year-on-year growth rates of 5.7%, 0.4%, 4.1%, 16.3%, and 22.4%, respectively [1] - Store counts for each brand were 992, 297, 527, 271, and 54, with year-on-year changes of 3.3%, -6%, 1.9%, 4.6%, and 3.8% [1] - Store efficiency (sales per store) was 1.87 million, 1.31 million, 0.94 million, 1.45 million, and 4.40 million yuan, with year-on-year growth of 2.2%, 6.5%, 2.2%, 10.7%, and 18.0% [1] Channel Performance - Revenue by channel in FY2026H1 was 1.180 billion from direct sales, 1.442 billion from distribution, and 753 million from online sales, with year-on-year growth of 5.7%, 0.3%, and 25.1% [1] - The number of direct and distribution stores was 512 and 1,651, respectively, with year-on-year growth of 4% and 1% [1] - Direct store efficiency and distribution single-store sales were 230,000 and 87,000 yuan per half year, with year-on-year growth of 1.3% and a decline of 1.1% [1] Membership and Retail Performance - As of December 31, 2025, retail sales contributed by members accounted for over 80% of total sales, remaining stable year-on-year [1] - The number of active member accounts was 590,000, reflecting a year-on-year increase of 9% [1] - The number of member accounts with annual purchases exceeding 5,000 yuan was over 340,000, growing by 3% [1] Profitability Metrics - Gross margin in FY2026H1 was 66.5%, an increase of 1.4 percentage points year-on-year [2] - By brand, gross margins were as follows: JNBY 69.4%, Su Xie 67.5%, jnby by JNBY 60.2%, LESS 70.5%, and emerging brands 48.8%, with year-on-year changes of 1.8, 2.0, 1.8, 1.7, and -3.6 percentage points [2] - The net profit margin was 20.0%, up 0.9 percentage points year-on-year [2] Expense Analysis - In FY2026H1, the sales, management, and financial expense ratios were 32.4%, 9.2%, and 0.17%, with year-on-year increases of 0.1, 0.6, and a decrease of 0.17 percentage points [2] - The increase in management expenses was primarily due to higher spending in product design and R&D departments [2] Inventory and Receivables - Ending inventory in FY2026H1 was 1.02 billion yuan, a year-on-year increase of 9.4% [3] - Accounts receivable stood at 220 million yuan, remaining stable, with a turnover period of 9 days, a decrease of 1 day year-on-year [3] - Accounts payable was 308 million yuan, up 29.2% year-on-year, with a turnover period of 44 days, a decrease of 12 days [3] Investment Outlook - Short-term revenue growth has been strong since the beginning of the year [3] - The company has significant room for expansion in its growth and emerging brands, with potential for improved store efficiency through various strategies [3] - In the medium to long term, fan loyalty is expected to support stable gross margins and further growth in net profit margins [3] - Revenue forecasts for FY26-28 are 6.004 billion, 6.396 billion, and 6.806 billion yuan, with year-on-year growth of 8.21%, 6.53%, and 6.41% [3] - Net profit forecasts for FY26-28 are 971 million, 1.040 billion, and 1.115 billion yuan, with year-on-year growth of 8.72%, 7.08%, and 7.24% [3] - Corresponding EPS forecasts for FY26-28 are 1.86, 1.92, and 2.09 yuan, with a PE ratio of 9.4, 9.1, and 8.3X based on the closing price of 20.08 HKD on February 26, 2026 [3]

Core Viewpoint - The company reported better-than-expected performance for 1HFY26, with revenue of 3.376 billion yuan, a year-on-year increase of 7.0%, and a net profit attributable to shareholders of 674 million yuan, up 12.5% [1][2] Financial Performance - Revenue breakdown by channel for 1HFY26 shows direct sales, distribution, and e-commerce channels grew by 5.7%, 0.3%, and 25.1% respectively, reaching 1.181 billion, 1.442 billion, and 753 million yuan [1] - The company added 20 direct stores and 26 distribution stores, bringing the total to 512 and 1,630 stores respectively, while comparable store sales declined by 2.2% [1] - The gross margin for 1HFY26 increased by 1.4 percentage points to 66.5%, driven by improved pricing strategies despite stable retail discounts [2] - Operating cash flow rose by 21% year-on-year to 996 million yuan, indicating healthy operations [2] Membership and Customer Engagement - The number of member accounts with total purchases exceeding 5,000 yuan increased by approximately 10,000 to over 340,000 compared to the end of FY25 [2] Growth Outlook - The company is expected to achieve its retail target of 10 billion yuan for FY26, supported by strong terminal sales performance compared to peers [2] Profit Forecast and Valuation - The profit forecasts for FY26 and FY27 have been raised by 7% and 9% to 988 million and 1.069 billion yuan respectively, with the current stock price corresponding to 9.7 and 8.8 times FY26/27 P/E [2] - The target price has been adjusted upward by 5% to 24.97 HKD, representing a 24% upside potential from the current price [2]

Group 1 - Citigroup downgraded the rating of CLP Holdings from "Buy" to "Neutral" due to challenges in the profitability outlook of its overseas business [1] - Despite the downgrade, Citigroup does not recommend a "Sell" rating for CLP, as its dividends remain sustainable supported by its Hong Kong operations [1] - The net profit forecast for CLP for the years 2026 to 2028 has been reduced by 5% to 7%, reflecting expectations of a U.S. interest rate cut and a lower weighted average cost of capital [1] Group 2 - Citigroup raised the target price for CLP by 2.6% to HKD 78, anticipating a dividend yield of 4.4% in 2026, which is considered reasonable [1] - Among Hong Kong utility stocks, Citigroup is most optimistic about China Resources Power, which has a dividend yield exceeding 6% [1] - Citigroup also favors Cheung Kong Infrastructure and Power Assets Holdings, as the substantial proceeds from the sale of the UK electricity grid can be utilized for future acquisitions [1]

Core Viewpoint - BeiGene achieved a revenue of $5.34 billion in 2025, representing a year-on-year increase of 40%, with product revenue of $5.28 billion, slightly exceeding previous management guidance of $5-5.3 billion [1] Group 1: Financial Performance - The company reported a net profit of $290 million, recovering from a loss of $640 million in the previous year, marking a turnaround in recurring business [1] - Management expects revenue to reach $6.2-6.4 billion in 2026, with GAAP operating profit projected at $700-800 million [1] Group 2: Product Performance - Zanubrutinib generated $3.93 billion in revenue for the year, up 49% year-on-year, with U.S. sales of $2.8 billion (up 45%), European sales of $600 million (up 66%), and Chinese sales of $340 million (up 33%) [1] - In Q4 2025, Zanubrutinib revenue was $1.15 billion, reflecting a quarter-on-quarter increase of 10% and a year-on-year increase of 38% [1] - Tislelizumab achieved $740 million in revenue for the year, a 19% increase year-on-year, with Q4 2025 revenue of $180 million, down 5% quarter-on-quarter but up 18% year-on-year [1] - Revenue from cooperative products in China reached $620 million, a 20% increase year-on-year, driven by growth in Duzallo and Belantamab Mafodotin [1] Group 3: Future Catalysts - Key catalysts for 1H26 include the approval of Sotorasib for R/R MCL in the U.S. and interim analysis for Zanubrutinib in 1L MCL Phase III trials [2] - In 2H26, the company plans to submit an accelerated approval application for BTK CDAC based on Phase II clinical data for R/R CLL and initiate Phase III trials for Sotorasib in combination therapy for multiple myeloma [2] - The revenue forecasts for FY26 and FY27 are maintained at $6.4 billion and $7.1 billion, respectively, with slight adjustments to net profit estimates reflecting increased R&D expenditures [2] - The target price is set at HKD 212.09, maintaining an "outperform" rating based on a DCF model with a WACC of 9% and a perpetual growth rate of 4% [2]

Core Viewpoint - Jiangnan Buyi reported a strong performance for the first half of the 2026 fiscal year, with revenue of 3.376 billion yuan, a year-on-year increase of 7.0%, and a net profit attributable to shareholders of 674 million yuan, up 12.5% year-on-year, exceeding expectations due to better-than-expected gross margin improvement [1] Group 1 - The company declared an interim dividend of 0.52 HKD, corresponding to an interim payout ratio of approximately 37% [1] - The company is expected to achieve its retail target of 10 billion yuan for the 2026 fiscal year, driven by better-than-industry performance in terminal sales [1] - The investment bank raised its profit forecasts for the company for the 2026 and 2027 fiscal years by 7% and 9%, respectively, to 988 million yuan and 1.069 billion yuan [1] Group 2 - The investment bank maintained an "outperform" rating for the company and raised the target price by 5% to 24.97 HKD [1]

Group 1 - The core viewpoint of the report indicates that Chow Tai Fook's operational performance for the first half of the fiscal year 2026 meets expectations, with adjusted recurring profits reaching HKD 1.47 billion, accounting for 52% of the bank's full-year forecast [1] - The profit growth of Chow Tai Fook Life Insurance is identified as the main driver across all operational segments [1] - The interim dividend per share is set at HKD 0.28, representing a 3% increase compared to the same period last year, which is considered an unexpected positive surprise [1] Group 2 - The report mentions that Chow Tai Fook is expected to be approved for inclusion in the southbound trading on March 9, which could act as a catalyst for valuation re-evaluation, particularly for yield-seeking investors [1] - The bank maintains a "outperform" rating for Chow Tai Fook, with a target price set at HKD 8.8 [1]

Group 1 - The core viewpoint of the article highlights that Galaxy Entertainment reported strong quarterly performance, with EBITDA increasing by 29% quarter-on-quarter to HKD 4.3 billion, exceeding market consensus expectations [1] - The company declared a final dividend of HKD 0.8 per share, resulting in a payout ratio of 64% for the second half of 2025, an increase from 58% in the first half of 2025 and 50% for the fiscal year 2024 [1] - Management expressed intentions to maintain a dividend payout of at least 65% of profits in the future, indicating strong financial capacity to increase dividends [1] Group 2 - Goldman Sachs noted potential impacts on gaming and tourism demand due to the upcoming National People's Congress from March 4 to 11 [1] - The firm slightly adjusted Galaxy Entertainment's EBITDA forecast for the fiscal year 2026 to 2027, with changes of less than 1% [1] - The 12-month target price for the stock was revised down from HKD 54 to HKD 53.4, while maintaining a "Buy" rating, as the current valuation remains attractive at an enterprise value multiple of 10 times the fiscal year 2026 forecast [1]

Core Insights - Nvidia is planning to launch a new processor designed to help clients like OpenAI develop faster and more efficient AI tools, which could reshape the AI competitive landscape [1] Group 1: Product Development - Nvidia is developing a new "inference" computing system that will change how AI models respond to user queries [1] - The new platform is set to be unveiled next month at the GTC developer conference in San Jose [1] - The system will utilize chips designed by the startup Groq [1] Group 2: Client Relationships - OpenAI is reportedly set to become one of the largest customers for this new processor, marking a significant win for Nvidia [1]